Overview

Observational Study to Evaluate the Safety of LevemirĀ® in Diabetes

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This observational study is conducted in North America. The aim of this observational study is to evaluate the incidence of adverse events while using LevemirĀ® under normal clinical practice conditions.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Detemir